Keytruda sales power Merck to quarterly beat
Go back to Keytruda sales power Merck to quarterly beat| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 66.05 +1.42 (2.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.63 | 52 Week High | $77.12 | |||
| Open | $65.30 | 52 Week Low | $49.03 | |||
| Day High | $66.38 | P/E | 42.89 | |||
| Day Low | $65.00 | EPS | $1.54 | |||
| Volume | 9,413,953 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 135.17 -0.8 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.97 | 52 Week High | $65.46 | |||
| Open | $137.24 | 52 Week Low | $47.97 | |||
| Day High | $137.98 | P/E | 91.95 | |||
| Day Low | $134.88 | EPS | $1.47 | |||
| Volume | 10,284,223 | |||||
